Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874

Cristina Kirkegaard-Biosca^{1

2}, Ester Del Barrio-Tofiño³, Miguel Villamarín¹, Nieves Larrosa^{2

3

4}, David Campany⁵, Juan José González-López^{2

3

4}, Ricard Ferrer^{2

6

7}, Belén Viñado³, Laura Doménech⁵, Julia Sellarès-Nadal^{1

2}, Laura Escolà-Vergé^{2

4

8}, Nuria Fernández-Hidalgo^{1

2

4}, Ibai Los-Arcos^{1

2

4}

Affiliations

¹ Infectious Diseases Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
² Department of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
³ Microbiology Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
⁴ CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
⁵ Pharmacy Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
⁶ Critical Care Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
⁷ Sepsis Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
⁸ Infectious Diseases Unit, Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.

Published Erratum

Cristina Kirkegaard-Biosca et al. Antibiotics (Basel). 2024.

. 2024 Dec 24;14(1):4.

doi: 10.3390/antibiotics14010004.

¹ Infectious Diseases Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
² Department of Medicine, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
³ Microbiology Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
⁴ CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
⁵ Pharmacy Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
⁶ Critical Care Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
⁷ Sepsis Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
⁸ Infectious Diseases Unit, Internal Medicine Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.

Abstract

Error in Table 2 [...].

Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria.
Kirkegaard-Biosca C, Del Barrio-Tofiño E, Villamarín M, Larrosa N, Campany D, González-López JJ, Ferrer R, Viñado B, Doménech L, Sellarès-Nadal J, Escolà-Vergé L, Fernández-Hidalgo N, Los-Arcos I. Kirkegaard-Biosca C, et al. Antibiotics (Basel). 2024 Sep 12;13(9):874. doi: 10.3390/antibiotics13090874. Antibiotics (Basel). 2024. PMID: 39335047 Free PMC article.

1. Kirkegaard-Biosca C., del Barrio-Tofiño E., Villamarín M., Larrosa N., Campany D., González-López J.J., Ferrer R., Viñado B., Doménech L., Sellarès-Nadal J., et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics. 2024;13:874. doi: 10.3390/antibiotics13090874. - DOI - PMC - PubMed